{"count": 2, "results": [{"_id": "6146394", "pmid": 6146394, "title": "Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.", "journal": "Can J Physiol Pharmacol", "authors": ["Beaulieu G", "Grimes D", "Muirhead C", "Oshiro G"], "date": "1984-06-01T00:00:00Z", "doi": "10.1139/y84-098", "meta_date_publication": "1984 Jun", "meta_volume": "62", "meta_issue": "6", "meta_pages": "610-6", "score": 50047.016, "text_hl": "However, the beta-blocking effects of these two drugs predominated in the anesthetized closed-chest @SPECIES_9615 @@@dog@@@, conscious @SPECIES_9615 @@@dog@@@ and @SPECIES_9527 @@@monkey@@@. @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@, @CHEMICAL_Nadolol @CHEMICAL_MESH:D009248 @@@nadolol@@@, and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@, which lack partial agonistic activity, produced cardiovascular @<m>DISEASE_Nephrosis_Lipoid</m> @DISEASE_MESH:D009402 @@@changes@@@ characteristic of this type of beta-blocker in the animal preparation in which they were tested. ", "citations": {"NLM": "Beaulieu G, Grimes D, Muirhead C, Oshiro G. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity. Can J Physiol Pharmacol. 1984 Jun;62(6):610-6. PMID: 6146394", "BibTeX": "@article{6146394, title={Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.}, author={Beaulieu G and Grimes D and Muirhead C and Oshiro G}, journal={Can J Physiol Pharmacol}, volume={62}, number={6}, pages={610-6}}"}}, {"_id": "12389881", "pmid": 12389881, "title": "Symptomatic orthostasis with extended-release nifedipine and protease inhibitors.", "journal": "Pharmacotherapy", "authors": ["Rossi DR", "Rathbun RC", "Slater LN"], "date": "2002-10-01T00:00:00Z", "doi": "10.1592/phco.22.15.1312.33478", "meta_date_publication": "2002 Oct", "meta_volume": "22", "meta_issue": "10", "meta_pages": "1312-6", "score": 50040.074, "text_hl": "Subsequent administration of antiretroviral therapy containing @CHEMICAL_Ritonavir @CHEMICAL_MESH:D019438 @@@ritonavir@@@ and @CHEMICAL_Indinavir @CHEMICAL_MESH:D019469 @@@indinavir@@@ with extended-release @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ resulted in recurrence of his @DISEASE_Headache @DISEASE_MESH:D006261 @@@orthostatic symptoms@@@. Discontinuation of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, and @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ dosage reduction by 50% were effective in managing his orthostatic @<m>DISEASE_Nephrosis_Lipoid</m> @DISEASE_MESH:D009402 @@@changes@@@. ", "citations": {"NLM": "Rossi DR, Rathbun RC, Slater LN. Symptomatic orthostasis with extended-release nifedipine and protease inhibitors. Pharmacotherapy. 2002 Oct;22(10):1312-6. PMID: 12389881", "BibTeX": "@article{12389881, title={Symptomatic orthostasis with extended-release nifedipine and protease inhibitors.}, author={Rossi DR and Rathbun RC and Slater LN}, journal={Pharmacotherapy}, volume={22}, number={10}, pages={1312-6}}"}}]}